Can You Take Escitalopram and Citalopram Together? Understanding This SSRI Combination
Is it safe to combine escitalopram and citalopram? Learn the FDA data, pharmacology, and why dual SSRI use requires medical supervision.
Lithium and diclofenac are documented to interact at a moderate severity level, and patients using both medications together require careful monitoring for signs of lithium toxicity. While the combination is not absolutely contraindicated, healthcare providers consider this a clinically significant pairing that demands watchfulness and regular communication between you and your medical team.
According to drug labeling information reviewed by the National Library of Medicine, the interaction between diclofenac (a nonsteroidal anti-inflammatory drug, or NSAID) and lithium is classified as moderate in severity. The source record directs healthcare providers to monitor patients for signs of lithium toxicity during concomitant use. This means that when these two drugs are taken together, there is a recognized risk that lithium levels in your bloodstream could rise to harmful levels, and your healthcare team needs to watch for that possibility.
The interaction source comes from NLP (natural language processing) analysis of diclofenac drug labeling, updated as of May 2026. This reflects current FDA-reviewed pharmaceutical information.
To make sense of this interaction, it helps to know what each drug does and why they might affect one another.
What is lithium? Lithium is a medication used primarily to treat bipolar disorder and certain types of depression. It works by affecting neurotransmitter activity in the brain. Lithium has a narrow therapeutic window, meaning the difference between a helpful dose and a toxic dose is relatively small. Your body excretes (eliminates) lithium mainly through the kidneys, and maintaining the right blood level of lithium is crucial to both its effectiveness and safety.
What is diclofenac? Diclofenac is an NSAID—a class of pain-relieving and anti-inflammatory drugs. Common NSAIDs include ibuprofen and naproxen. Diclofenac is often used for moderate pain, arthritis, and inflammatory conditions.
Why might they interact? The source record does not specify a documented mechanism for this interaction. However, general pharmacology knowledge shows that NSAIDs can affect how the kidneys handle various substances, including lithium. When kidney function is altered by an NSAID, lithium excretion may be reduced, potentially causing lithium to accumulate in the body to higher-than-intended levels. This accumulation is the basis for monitoring concern. That said, the absence of a mechanism statement in the source record means we cannot point to a single, well-defined pathway that has been formally documented for the lithium-diclofenac pair. The interaction itself is documented; the precise mechanism is not specified in the labeling information reviewed here.
What is lithium toxicity? Lithium toxicity ranges from mild to severe. Early signs can include tremor, nausea, vomiting, diarrhea, confusion, and slurred speech. More serious toxicity can affect the heart rhythm and kidneys. This is why monitoring is essential: catching a rising lithium level before symptoms appear allows for dose adjustment or medication change before harm occurs.
While any patient taking both lithium and diclofenac together should be aware of this interaction, certain situations warrant heightened attention:
Hypothetical scenario 1: A 45-year-old person with bipolar disorder has been taking lithium 900 mg daily for two years with stable mood and normal lithium blood levels. They develop osteoarthritis pain in their knee and their physician prescribes diclofenac 50 mg twice daily. Because of the documented interaction, the physician orders a lithium blood level check two to three weeks after starting diclofenac. The check reveals that the lithium level has risen by 20%, still within acceptable range but trending upward. The physician and patient discuss this result: they might reduce the lithium dose slightly, increase the frequency of monitoring, or try a different pain reliever. This is the monitoring process at work.
Hypothetical scenario 2: A different patient takes lithium and begins diclofenac but does not inform their prescriber or pharmacist that they are on lithium, or the prescriber forgets to check the drug interaction. Over several weeks, the patient notices increasing tremor, mild nausea, and difficulty concentrating. A lithium blood level check reveals toxic levels. Had the interaction been flagged and monitored proactively, the rising level could have been detected and managed before symptoms appeared. This illustrates why transparency and communication are critical.
If you take lithium and need pain relief or anti-inflammatory medication, or if you take diclofenac and have been prescribed lithium, here are questions and topics to raise:
Do not start, stop, skip, or change either medication on your own. All decisions about managing this pair should be made with your prescribing physician and pharmacy team.
Ready to check your medications for interactions? Visit checkdruginteractions.com to search your complete medication list and get a personalized report. Always confirm any medication questions or changes with your pharmacist or physician—they have your full medical history and can give you guidance tailored to your specific situation.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Is it safe to combine escitalopram and citalopram? Learn the FDA data, pharmacology, and why dual SSRI use requires medical supervision.
Lisinopril and potassium can interact dangerously. FDA data explains risks, symptoms to watch, and when to call your doctor.
Clinical guide to fluoxetine-tamoxifen interaction. Covers CYP2D6 inhibition, endoxifen metabolism, and monitoring parameters with FDA data.